Skip to main content
Rupal Bhatt, MD, Oncology, Boston, MA

Rupal Satish Bhatt MD


Assistant Professor, Medicine, Harvard Medical School Clinical Fellow, Hematology-Oncology, Beth Israel Deaconess Medical Cente

Join to View Full Profile
  • 330 Brookline AveRw-563Boston, MA 02215

  • Phone+1 617-667-5288

Dr. Bhatt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2002 - 2006
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2000 - 2002
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 2000

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2002 - 2025

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Study of Cathepsin B Inhibition in VEGFR TKI Treated Human Renal Cell Carcinoma Xenografts  
    David A Frank, Rupal S Bhatt, Seth L Alper, Prateek Khanna, Nature

Press Mentions

  • Promising Triple Therapy Approach Identified for Renal Cell Carcinoma
    Promising Triple Therapy Approach Identified for Renal Cell CarcinomaJanuary 21st, 2021
  • Beth Israel Deaconess Medical Center Expert Sources Available for Prostate Health Month
    Beth Israel Deaconess Medical Center Expert Sources Available for Prostate Health MonthAugust 23rd, 2019
  • Blood Test Could Detect Kidney Cancer up to Five Years Prior to Clinical Diagnosis
    Blood Test Could Detect Kidney Cancer up to Five Years Prior to Clinical DiagnosisAugust 16th, 2018
  • Join now to see all

Grant Support

  • Mechanism Of Acquired Resistance To VEGF-R Antagonists In RCCNational Cancer Institute2010–2011

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: